PPP2R2A and non-small cell lung carcinoma: FAM122A has recently been shown to control the activation of PP2A/B55α in response to massive replication stress caused by CHK1 inhibition in NSCLC cell lines, which activates the WEE1 kinase, a negative regulator of CDK123.